EOD Regional Nodes

This input is used in derivation

Notes

**Note 1:** **Regional nodes and nodes, NOS** * Code only regional nodes and nodes, NOS in this field. Distant nodes are coded in EOD Mets. **Note 2:** **Mesenteric nodes** * The specific location of the mesenteric nodes determines whether they are regional or distant. * If the specific location is not described, code in EOD Regional Nodes. **Note 3:** **Porta hepatic nodes** * Porta hepatic nodes are recorded as distant for Body and Tail and should be coded in EOD Mets. * If the specific location for hepatic nodes is not described, code in EOD Regional Nodes. **Note 4:** **CLINICAL AND PATHOLOGICAL codes** * This schema has lymph node codes that are defined as **CLINICAL** assessment only or **PATHOLOGICAL** assessment only. **No surgical resection** * Use **CLINICAL** assessment only codes (700, 725, 775) when there is a clinical work up only and there is **NO surgical resection of the primary tumor or site** WITH * Any microscopic examination of regional lymph nodes, which includes FNA, core biopsy, sentinel node biopsy, lymph node excision, or lymph node dissection done during the clinical work up. **Surgical resection without neoadjuvant therapy** * Use **PATHOLOGICAL** assessment only codes (300, 700) when there is a **surgical resection of the primary tumor or site** WITH * Any microscopic examination of regional lymph nodes, which includes FNA, core biopsy, sentinel node biopsy, lymph node excision done or lymph node dissection performed. **Surgical resection after neoadjuvant therapy** * If patient has neoadjuvant therapy, and the clinical assessment is equal to or greater than the pathological assessment, then the clinical assessment codes take priority. Otherwise, code the pathologic assessment. * See ***EOD 2018 General Instructions*** for further instructions on coding cases with neoadjuvant therapy, https://seer.cancer.gov/tools/staging/eod/.

Default

999

NAACCR Item

NAACCR #774
Code Description SS2018 N
000 No regional lymph node involvement NONE
300 **PATHOLOGICAL ASSESSMENT ONLY** All sites - Anterior, NOS - Common hepatic artery - Hepatic, NOS - Inferior to head and body of pancreas - Lateral aortic (lumbar) - Pancreaticoduodenal (anterior, posterior) - Peripancreatic, NOS - Posterior, NOS - Proximal mesenteric (anterior, posterior) - Retroperitoneal - Superior mesenteric - Superior to head and body of pancreas Pancreas Head (C250) - Common bile duct (pericholedochal) - Lateral wall (right) - Portal vein - Pyloric (infrapyloric, retropyloric, subpyloric, suprapyloric, NOS) Pancreas Body and Tail (C251-C252) - Gastroepiploic (gastro-omental, left) - Pancreaticosplenic (pancreaticolienal) - Splenic (artery, hilum, lineal) - Suprapancreatic Pancreas Other (C253-C254, C257-C259) - Celiac - Common bile duct (pericholedochal) - Gastroepiploic (gastro-omental) - Lateral wall right - Pancreaticosplenic (pancreaticolienal) - Portal vein - Pyloric (infrapyloric, retropyloric, subpyloric, suprapyloric, NOS) - Splenic (artery, hilum, lineal) - Suprapancreatic RN
700 **PATHOLOGICAL ASSESSMENT ONLY** Pancreas Body Tail (C251, C252) (see code 300 for Pancreas Other, or EOD Mets for Pancreas Head) - Celiac D
725 **CLINICAL ASSESSMENT ONLY** One-three positive nodes clinically OR stated as Clinical N1 RN
775 **CLINICAL ASSESSMENT ONLY** Four or more positive nodes clinically OR stated as Clinical N2 RN
800 Positive nodes, number unknown Unknown if clinical or pathological Regional lymph node(s), NOS Lymph node(s), NOS RN
999 Unknown; regional lymph node(s) not stated Regional lymph node(s) cannot be assessed Not documented in medical record Death Certificate Only U
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) Kakar, S., Pawlik, T.M., Vauthey, J.N., et al. **Exocrine Pancreas**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cacer Staging Manual. 8th Ed. New York: Springer; 2017